Alnylam Pharmaceuticals CEO Yvonne Greenstreet buys and sells shares.

Alnylam Pharmaceuticals Inc. (ALNY) has announced that Yvonne Greenstreet, Director and Chief Executive Officer, has made several transactions involving the purchase and sale of shares. Specifically, on May 30, 2025, Greenstreet acquired 19,559 shares at $118.05 per share, while also selling 6,171 shares at $306 per share. Additionally, on June 2, 2025, she sold 19,297 shares at $306 per share, and purchased 12,081 shares at $119.13 per share. Furthermore, on June 2, 2025, Greenstreet acquired 12,080 shares at $119.13 per share and 7,217 shares at $118.05 per share. Finally, on May 30, 2025, she sold 25,469 shares at $304 per share.